Search research articles
Contact Us
Filters
Showing results (11-20 of 18) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 18 results.
Journal of the National Comprehensive Cancer Network : JNCCN
|
July 8, 2020
NCCN Policy Summit: Defining, Measuring, and Applying Quality in an Evolving Health Policy Landscape and the Implications for Cancer Care
Lindsey A M Bandini, Leigh Gallo, Terrell Johnson, et al.
The Journal of Investigative Dermatology
|
April 4, 2008
Potential of fibroblast cell therapy for recessive dystrophic epidermolysis bullosa
Tracy Wong, Luke Gammon, Lu Liu, et al.
BMC Primary Care
|
September 28, 2023
Results from the BETTER WISE trial: a pragmatic cluster two arm parallel randomized controlled trial for primary prevention and screening in primary care during the COVID-19 pandemic
Donna Patricia Manca, Carolina Fernandes, Aisha Lofters, et al.
BMJ Open
|
April 16, 2024
Chronic disease prevention and screening outcomes for patients with and without financial difficulty: a secondary analysis of the BETTER WISE cluster randomised controlled trial
Kris Aubrey-Bassler, Dhruvesh Patel, Carolina Fernandes, et al.
The Journal of Investigative Dermatology
|
May 15, 2007
Patients with recessive dystrophic epidermolysis bullosa develop squamous-cell carcinoma regardless of type VII collagen expression
Celine Pourreyron, Georgie Cox, Xin Mao, et al.
BMC Primary Care
|
May 6, 2024
Harmonization of clinical practice guidelines for primary prevention and screening: actionable recommendations and resources for primary care
Carolina Fernandes, Denise Campbell-Scherer, Aisha Lofters, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
January 18, 2022
Adoption of Patient-Generated Health Data in Oncology: A Report From the NCCN EHR Oncology Advisory Group
Peter D Stetson, Nadine J McCleary, Travis Osterman, et al.
Leukemia & Lymphoma
|
February 17, 2015
A phase I trial of two sequence-specific schedules of decitabine and vorinostat in patients with acute myeloid leukemia
Jonathan How, Mark D Minden, Leber Brian, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 18) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 18 results.
Journal of the National Comprehensive Cancer Network : JNCCN
|
July 8, 2020
NCCN Policy Summit: Defining, Measuring, and Applying Quality in an Evolving Health Policy Landscape and the Implications for Cancer Care
Lindsey A M Bandini, Leigh Gallo, Terrell Johnson, et al.
The Journal of Investigative Dermatology
|
April 4, 2008
Potential of fibroblast cell therapy for recessive dystrophic epidermolysis bullosa
Tracy Wong, Luke Gammon, Lu Liu, et al.
BMC Primary Care
|
September 28, 2023
Results from the BETTER WISE trial: a pragmatic cluster two arm parallel randomized controlled trial for primary prevention and screening in primary care during the COVID-19 pandemic
Donna Patricia Manca, Carolina Fernandes, Aisha Lofters, et al.
BMJ Open
|
April 16, 2024
Chronic disease prevention and screening outcomes for patients with and without financial difficulty: a secondary analysis of the BETTER WISE cluster randomised controlled trial
Kris Aubrey-Bassler, Dhruvesh Patel, Carolina Fernandes, et al.
The Journal of Investigative Dermatology
|
May 15, 2007
Patients with recessive dystrophic epidermolysis bullosa develop squamous-cell carcinoma regardless of type VII collagen expression
Celine Pourreyron, Georgie Cox, Xin Mao, et al.
BMC Primary Care
|
May 6, 2024
Harmonization of clinical practice guidelines for primary prevention and screening: actionable recommendations and resources for primary care
Carolina Fernandes, Denise Campbell-Scherer, Aisha Lofters, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
January 18, 2022
Adoption of Patient-Generated Health Data in Oncology: A Report From the NCCN EHR Oncology Advisory Group
Peter D Stetson, Nadine J McCleary, Travis Osterman, et al.
Leukemia & Lymphoma
|
February 17, 2015
A phase I trial of two sequence-specific schedules of decitabine and vorinostat in patients with acute myeloid leukemia
Jonathan How, Mark D Minden, Leber Brian, et al.
Page
of 2